Login / Signup
Intravitreal slow-releasing dexamethasone implant for idiopathic neuroretinitis.
Osman Çekiç
Samet Gulkas
Published in:
European journal of ophthalmology (2020)
Idiopathic neuroretinitis can be treated with intravitreal dexamethasone implant.
Keyphrases
</>
vascular endothelial growth factor
diabetic retinopathy
age related macular degeneration
high dose
low dose
soft tissue
endothelial cells
newly diagnosed